A controlled clinical study on the effectiveness of Arsenicum iodatum in LM potency in managing Allergic Rhinitis among Paediatric age group
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Significant reduction in the symptom severity assessed using the Total Nasal Symptom Severity (TNSS) Score in the intervention group compared to the baseline.
研究概览
简要总结
Randomised controlled trial in which 60 cases of patients within the age group 2 years to 18 years presenting with symptoms of Allergic rhinitis from the OPD, IPD, rural centers, School health awareness programmes of Sarada Krishna Homoeopathic Medical College will be evaluated. Study will be based on analysing the effectiveness of Arsenicum iodatum in fifty millesimal potencies in treatment of allergic rhinitis among paediatric age group. The case details will be recorded in standardized and pre-structured case format of Sarada Krishna Homoeopathic Medical College and will be analyzed using total nasal symptom severity score scale at the baseline and then the totality will be erected and then the medicine will be administered orally.
The patients will be divided randomly into two groups, intervention group of 30 cases prescribed with Arsenicum iodatum in fifty millesimal potencies and a control group of 30 cases prescribed with Natrum sulphuricum 6X respectively and will be analysed sing total nasal symptom severity score scale at the baseline and will be analysed for every two weeks for a period of 2 months. Thus to understand the significant reduction in the symptom severity in the intervention group in order to study the effectiveness of Arsenicum iodatum in treating allergic rhinitis among paediatric age group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 2.00 Year(s) 至 18.00 Year(s)（—）
- 性别
- All
入选标准
- •Children and adolescents aged between 2 and 18 years Both male and female participants Diagnosis primarily determined by clinical symptoms Individuals experiencing repeated episodes of allergic rhinitis Evaluation of improvement based on the reduction of symptoms.
排除标准
- •Patients with additional respiratory disorders or associated complications.
- •Patients suffering from other severe systemic diseases.
结局指标
主要结局
Significant reduction in the symptom severity assessed using the Total Nasal Symptom Severity (TNSS) Score in the intervention group compared to the baseline.
时间窗: 2 months
次要结局
- Disappearance of symptoms will be noted.(2 months)
- General Improvement of the patient will be noted(2 months)
研究者
Dr Geo Paul
Sarada Krishna Homoepathic Medical College